Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
about
The Regulation of DNA Damage Tolerance by Ubiquitin and Ubiquitin-Like ModifiersStructural basis of human DNA polymerase η-mediated chemoresistance to cisplatin.Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapyStructural and mechanistic studies of polymerase bypass of phenanthriplatin DNA damageN-Aroyl indole thiobarbituric acids as inhibitors of DNA repair and replication stress response polymerases.Sphingosine, a modulator of human translesion DNA polymerase activityAnalysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance.DNA polymerase η protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapyExpression of DNA translesion synthesis polymerase η in head and neck squamous cell cancer predicts resistance to gemcitabine and cisplatin-based chemotherapy.Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells.Ablation of XP-V gene causes adipose tissue senescence and metabolic abnormalities.Translesion DNA polymerases and cancerLeukotriene biosynthesis inhibitor MK886 impedes DNA polymerase activity.Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta.DNA polymerases and cancer.DNA damage tolerance: a double-edged sword guarding the genomeRAD18 polymorphisms are associated with platinum-based chemotherapy toxicity in Chinese patients with non-small cell lung cancer.Mechanisms of Post-Replication DNA RepairDNA polymerase eta and chemotherapeutic agents.Biological and therapeutic relevance of nonreplicative DNA polymerases to cancer.ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway.DNA polymerase η modulates replication fork progression and DNA damage responses in platinum-treated human cells.Inhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents.Aberrant Kynurenine Signaling Modulates DNA Replication Stress Factors and Promotes Genomic Instability in Gliomas.Polη O-GlcNAcylation governs genome integrity during translesion DNA synthesis.Inhibiting DNA Polymerases as a Therapeutic Intervention against Cancer.A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas.Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesis.Association of POLK polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.[Advances of DNA damage repair and Cisplatin resistance mechanisms in lung cancer].Tuning the Optical Properties of Phenanthriplatin: Towards New Photoactivatable Analogues
P2860
Q26744520-59D40C61-65AF-4B45-B676-9E5CC3A23837Q27678705-3571F9EC-765E-4D84-B218-298B10E44223Q27678933-926D72DA-581B-4F14-975A-12E43B1E52BDQ27684330-636D4135-E0D3-4FA5-AAC7-BE37154560EBQ31117517-7E185704-77E6-4D92-9EE3-46549FA1522AQ33985368-DF9A0CF9-8C04-4C6F-9CC7-863214597CB6Q34132978-0023035D-5541-4EDC-B858-5A796B57C6E1Q34413771-3D96C5DE-3ED5-4B05-8069-9A7A066BD508Q35078304-41A81949-FBF1-44A8-A295-157C65C3D5D8Q35377658-F2809DF7-A570-448A-98CF-44D805894CA9Q35989743-CC4927C0-3C57-48E2-96CF-456CD82EEF1CQ36210704-0917AEE0-5E35-412C-B874-284D389432F7Q36626061-FC9B8175-62AE-46D8-A5EA-BF6DCCA301DFQ36646991-E841CCE7-52A8-4744-8D58-D58F8586858DQ37084895-9CC84E0B-F447-493E-BC21-3DFD707ED0E7Q37187991-CA573D4D-79B0-4C73-908B-40B71EFB0B3BQ37399367-A639833A-F0A5-4377-B24F-BC8CF269C85BQ37676241-39529ECE-E278-4FC4-ABB0-F86BD81C9DD6Q37807048-13AFDD7E-81D3-46EA-9BD9-0B059BEFEC95Q38026112-43C93BC3-B70B-49BF-B235-5CC96AA6A4EDQ38943647-9FB94F49-2C2E-4C88-AEAD-C6DA75D35539Q39061225-3A39A5F8-5FD7-44BA-91A3-5EE89073F666Q41093149-6D03D723-B22D-4B82-94B4-7D03334AFDB6Q41720039-527AE1AD-77C1-42B0-8A95-9F5C83AA0575Q47104269-C6ADFBB4-1DB9-43EC-A7C9-F2E3B7016A55Q47137568-A79D63DF-550F-4F70-8967-04F118EBDB16Q47239499-6B45BA3C-E933-449F-A9BA-14C2AB1860D8Q52717520-D5D9B5F7-1AF5-4474-AA5D-D841D8B1C70FQ54343399-430DE5AD-3E98-48ED-9F4A-36149AD23B95Q55434155-72BB3DDC-6361-4719-9C8F-BE005042107DQ56782217-949332FD-7DC4-41C3-8490-B8B3F16CE51E
P2860
Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Polymerase eta mRNA expression ...... h platinum-based chemotherapy.
@en
Polymerase eta mRNA expression ...... h platinum-based chemotherapy.
@nl
type
label
Polymerase eta mRNA expression ...... h platinum-based chemotherapy.
@en
Polymerase eta mRNA expression ...... h platinum-based chemotherapy.
@nl
prefLabel
Polymerase eta mRNA expression ...... h platinum-based chemotherapy.
@en
Polymerase eta mRNA expression ...... h platinum-based chemotherapy.
@nl
P2093
P50
P1476
Polymerase eta mRNA expression ...... th platinum-based chemotherapy
@en
P2093
Alberto Cambieri
Giorgio Scagliotti
Marco Volante
Marina Longo
Mauro Papotti
Paolo Ceppi
Silvia Novello
P304
P356
10.1158/1078-0432.CCR-08-1227
P407
P577
2009-02-01T00:00:00Z